NLS Pharma is a clinical-stage drug development company. Our R&D Focus is based on a strong scientific understanding of neurobehavioral and neurocognitive disorders and their pharmacognosia. Our patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.
Looking for a particular NLS Pharma AG employee's phone or email?
The NLS Pharma AG annual revenue was $34.2 million in 2026.
NLS Pharma AG is based in Zurich, Zurich.
The NAICS codes for NLS Pharma AG are [3254, 325, 32].
The SIC codes for NLS Pharma AG are [283, 80, 28].